The antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health. The study also finds...

For the first time, a study was conducted in Ukraine to coordinate the number of people with antibodies to the coronavirus SARS-CoV-2, the causative agent of COVID-19. Thus, according to preliminary...

By NewsDesk  @infectiousdiseasenews The majority of those infected with the coronavirus had neutralizing antibodies after more than a year, according to a study by the National Institute for Health and...

By NewsDesk  @bactiman63 A study by the Finnish Institute for Health and Welfare (THL) has found that a very large share of people infected with coronavirus in the spring still had detectable antibodies...

People who survive serious COVID-19 infections have long-lasting immune responses against the virus, according to a new study led by researchers at Massachusetts General Hospital (MGH). The study, published...